Brasso, C.; Bellino, S.; Bozzatello, P.; Montemagni, C.; Nobili, M.G.A.; Sgro, R.; Rocca, P.
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction. J. Clin. Med. 2023, 12, 6985.
https://doi.org/10.3390/jcm12226985
AMA Style
Brasso C, Bellino S, Bozzatello P, Montemagni C, Nobili MGA, Sgro R, Rocca P.
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction. Journal of Clinical Medicine. 2023; 12(22):6985.
https://doi.org/10.3390/jcm12226985
Chicago/Turabian Style
Brasso, Claudio, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Marco Giuseppe Alberto Nobili, Rodolfo Sgro, and Paola Rocca.
2023. "Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction" Journal of Clinical Medicine 12, no. 22: 6985.
https://doi.org/10.3390/jcm12226985
APA Style
Brasso, C., Bellino, S., Bozzatello, P., Montemagni, C., Nobili, M. G. A., Sgro, R., & Rocca, P.
(2023). Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction. Journal of Clinical Medicine, 12(22), 6985.
https://doi.org/10.3390/jcm12226985
